Erowid.org: Erowid Reference 345 : Neuropsychiatric manifestations following the use of 3,4-methylenedioxymethamphetamine (MDMA: 'Ecstasy') : Cohen RS, Cocores J

Erowid References Database

Cohen RS, Cocores J. “Neuropsychiatric manifestations following the use of 3,4-methylenedioxymethamphetamine (MDMA: 'Ecstasy')”. Prog Neuropsychopharmacol Biol Psychiatry. 1997 May;21(4):727-34. <a name="ref">Cohen RS, Cocores J.</a> <a href="/references/345">"Neuropsychiatric manifestations following the use of 3,4-methylenedioxymethamphetamine (MDMA: 'Ecstasy')"</a> <i>Prog Neuropsychopharmacol Biol Psychiatry</i>. 1997 May;21(4):727-34.
Text Abstract (this page) Full Text - English (private) Show Articles by Cohen RS Cocores J Article IDs Erowid RefID: 345 PubMedID: unknown Collections Hofmann Collection MDMA Collection All References	Abstract Discusses the recurring side-effects associated with methylenedioxymethamphetamine (MDMA) consumption. The recreational use of 'Ecstasy'(MDMA's nickname), has been implicated in the onset of various psychological, neurological and organic complications. The constellation of adverse symptomatology associated with Ecstacy use include anxiety, panic attacks, disorientation, delusions, depression, suicidal ideations, flashback, rage reactions, psychosis, depersonalization, derealization, severe paranoia, and organic complications which include rhabdomyolysis, hepatitis, hemorrhage, coma and deaths in some instances. An original case report of a 17-yr-old male is presented, in which the Subject developed perpetual neuropsychiatric symptomatology after having consumed MDMA. This case shows that MDMA may induce long-lasting effects, even after an exposure. ((c) 1999 APA/PsycINFO, all rights reserved)
Comments and Responses to this Article #
Submit Comment

[ Cite HTML ]